Mark Peplow
Can GE yeast-derived malaria drug survive market obstacles?
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. “It’s been a dream ...
Market resistance slows progress of synthetic malaria drug
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. When Paris-based pharmaceutical giant ...
